FIELD: medicine.
SUBSTANCE: native human plasma mixed with Freund adjuvant in equal proportions is introduced into Syrian hamsters in single dose. Plasma is injected both in symmetrical axillary and inguinal regions, and intraperitoneally 0.1 ml in each point.
EFFECT: visceral amyloidosis simulated in a relatively short time.
1 ex, 2 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473133C2 |
| METHOD OF MODELLING EXPERIMENTAL AMYLOIDOSIS IN RATS | 2009 |
|
RU2410761C1 |
| METHOD FOR SIMULATING EXPERIMENTAL AMYLOID CARDIOPATHY IN RATS | 2013 |
|
RU2556571C1 |
| METHOD FOR SIMULATING GENERALISED AMYLOIDOSIS IN ANIMALS | 2013 |
|
RU2536556C2 |
| METHOD FOR SIMULATING EXPERIMENTAL AMYLOID THYREOPATHY IN RATS | 2020 |
|
RU2732008C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473134C2 |
| METHOD OF TREATMENT AN EXPERIMENTAL AMYLOID CARDIOPATHY IN RATS | 2017 |
|
RU2657844C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2381797C1 |
| METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC CONDITION IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2386415C1 |
| METHOD FOR MODELING EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2006 |
|
RU2306617C1 |
